| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Glands, Animal | 86 | 2022 | 448 | 10.590 |
Why?
|
| Breast Neoplasms | 53 | 2025 | 2602 | 5.400 |
Why?
|
| Triple Negative Breast Neoplasms | 14 | 2026 | 280 | 5.110 |
Why?
|
| Neoplastic Stem Cells | 24 | 2023 | 330 | 4.510 |
Why?
|
| Mammary Neoplasms, Animal | 15 | 2021 | 135 | 3.400 |
Why?
|
| Epithelial Cells | 37 | 2022 | 905 | 3.330 |
Why?
|
| Mammary Glands, Human | 13 | 2014 | 79 | 3.200 |
Why?
|
| Stem Cells | 18 | 2017 | 702 | 3.000 |
Why?
|
| Tumor Microenvironment | 17 | 2026 | 713 | 2.770 |
Why?
|
| Caseins | 39 | 2011 | 65 | 2.650 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 13 | 2018 | 67 | 2.600 |
Why?
|
| Mammary Neoplasms, Experimental | 24 | 2015 | 235 | 2.350 |
Why?
|
| Animals | 193 | 2026 | 33912 | 2.300 |
Why?
|
| Osteoarthritis, Knee | 7 | 2021 | 282 | 2.270 |
Why?
|
| Mice | 131 | 2026 | 18301 | 2.230 |
Why?
|
| Hyaluronic Acid | 7 | 2021 | 107 | 2.210 |
Why?
|
| Breast | 10 | 2022 | 215 | 2.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 24 | 2025 | 2026 | 2.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 11 | 2026 | 254 | 2.100 |
Why?
|
| Wnt Signaling Pathway | 11 | 2022 | 223 | 2.100 |
Why?
|
| Viscosupplements | 4 | 2018 | 8 | 1.690 |
Why?
|
| Cell Differentiation | 20 | 2020 | 1928 | 1.680 |
Why?
|
| RNA, Long Noncoding | 5 | 2023 | 218 | 1.670 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 8 | 2020 | 37 | 1.670 |
Why?
|
| Signal Transduction | 32 | 2025 | 4686 | 1.640 |
Why?
|
| Milk Proteins | 20 | 2007 | 95 | 1.550 |
Why?
|
| MicroRNAs | 9 | 2021 | 889 | 1.520 |
Why?
|
| Cell Transformation, Neoplastic | 17 | 2022 | 587 | 1.360 |
Why?
|
| Prolactin | 18 | 2011 | 142 | 1.310 |
Why?
|
| Wnt Proteins | 7 | 2013 | 191 | 1.260 |
Why?
|
| Protein Kinases | 6 | 2011 | 312 | 1.250 |
Why?
|
| RNA, Messenger | 40 | 2026 | 2550 | 1.230 |
Why?
|
| Neoplasm Metastasis | 10 | 2024 | 713 | 1.230 |
Why?
|
| Female | 148 | 2026 | 70963 | 1.210 |
Why?
|
| Injections, Intra-Articular | 7 | 2021 | 30 | 1.200 |
Why?
|
| Antineoplastic Agents | 8 | 2025 | 1826 | 1.190 |
Why?
|
| Cell Line, Tumor | 29 | 2026 | 3748 | 1.180 |
Why?
|
| DNA Damage | 10 | 2020 | 511 | 1.150 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 3 | 2022 | 35 | 1.120 |
Why?
|
| Tumor Suppressor Protein p53 | 12 | 2019 | 722 | 1.110 |
Why?
|
| RNA, Untranslated | 5 | 2012 | 109 | 1.110 |
Why?
|
| Radiation Tolerance | 4 | 2010 | 61 | 1.110 |
Why?
|
| Single-Cell Analysis | 2 | 2022 | 350 | 1.090 |
Why?
|
| beta Catenin | 10 | 2023 | 197 | 1.080 |
Why?
|
| GTPase-Activating Proteins | 6 | 2011 | 83 | 1.060 |
Why?
|
| Myeloid-Derived Suppressor Cells | 6 | 2021 | 57 | 1.060 |
Why?
|
| Macrophages | 7 | 2026 | 667 | 1.060 |
Why?
|
| Ecosystem | 3 | 2023 | 91 | 1.030 |
Why?
|
| Cell Proliferation | 21 | 2025 | 2465 | 1.010 |
Why?
|
| Mesoderm | 6 | 2021 | 106 | 1.000 |
Why?
|
| Gene Expression Profiling | 17 | 2016 | 1801 | 0.970 |
Why?
|
| STAT5 Transcription Factor | 14 | 2022 | 93 | 0.960 |
Why?
|
| Receptors, Progesterone | 11 | 2015 | 677 | 0.940 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2026 | 12 | 0.930 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2026 | 14 | 0.930 |
Why?
|
| Adenocarcinoma | 10 | 2023 | 972 | 0.910 |
Why?
|
| Humans | 116 | 2026 | 131163 | 0.910 |
Why?
|
| Adaptive Immunity | 2 | 2026 | 101 | 0.910 |
Why?
|
| Homeostasis | 4 | 2017 | 712 | 0.870 |
Why?
|
| CREB-Binding Protein | 1 | 2024 | 54 | 0.850 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2025 | 89 | 0.840 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 6 | 2014 | 37 | 0.840 |
Why?
|
| Protein Biosynthesis | 12 | 2026 | 569 | 0.830 |
Why?
|
| Carcinoma | 2 | 2020 | 291 | 0.810 |
Why?
|
| Cell Lineage | 7 | 2017 | 349 | 0.810 |
Why?
|
| Cell Self Renewal | 3 | 2018 | 48 | 0.780 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2014 | 950 | 0.770 |
Why?
|
| Histones | 4 | 2025 | 541 | 0.770 |
Why?
|
| Epithelium | 15 | 2015 | 335 | 0.760 |
Why?
|
| Neutrophils | 2 | 2024 | 371 | 0.750 |
Why?
|
| Trans-Activators | 10 | 2016 | 697 | 0.750 |
Why?
|
| Progesterone | 10 | 2015 | 439 | 0.740 |
Why?
|
| Epigenesis, Genetic | 5 | 2025 | 757 | 0.730 |
Why?
|
| Mice, Inbred BALB C | 15 | 2021 | 978 | 0.720 |
Why?
|
| Repressor Proteins | 6 | 2014 | 760 | 0.720 |
Why?
|
| Neoplasms | 10 | 2023 | 3016 | 0.710 |
Why?
|
| Estrogens | 7 | 2015 | 434 | 0.700 |
Why?
|
| Mice, Knockout | 18 | 2020 | 3819 | 0.700 |
Why?
|
| Disease Models, Animal | 14 | 2024 | 4697 | 0.690 |
Why?
|
| 5' Untranslated Regions | 2 | 2018 | 58 | 0.670 |
Why?
|
| Wnt1 Protein | 5 | 2019 | 71 | 0.670 |
Why?
|
| Mammary Tumor Virus, Mouse | 8 | 2019 | 100 | 0.670 |
Why?
|
| Biomarkers, Tumor | 6 | 2020 | 1586 | 0.660 |
Why?
|
| Receptors, Glucocorticoid | 7 | 2011 | 105 | 0.660 |
Why?
|
| Cell Division | 14 | 2015 | 718 | 0.660 |
Why?
|
| Mice, Transgenic | 24 | 2017 | 2326 | 0.660 |
Why?
|
| Transcription, Genetic | 20 | 2020 | 1363 | 0.660 |
Why?
|
| ErbB Receptors | 4 | 2019 | 286 | 0.650 |
Why?
|
| Claudins | 6 | 2022 | 29 | 0.650 |
Why?
|
| Apoptosis | 13 | 2021 | 1827 | 0.640 |
Why?
|
| Rats | 37 | 2016 | 3370 | 0.620 |
Why?
|
| Paracrine Communication | 4 | 2015 | 69 | 0.610 |
Why?
|
| STAT3 Transcription Factor | 2 | 2019 | 229 | 0.610 |
Why?
|
| Gene Expression Regulation | 15 | 2012 | 2323 | 0.600 |
Why?
|
| Immunotherapy | 3 | 2026 | 768 | 0.600 |
Why?
|
| Spindle Apparatus | 3 | 2015 | 50 | 0.600 |
Why?
|
| Chromosome Segregation | 2 | 2009 | 68 | 0.580 |
Why?
|
| Cell Polarity | 4 | 2016 | 117 | 0.570 |
Why?
|
| Stromal Cells | 4 | 2015 | 316 | 0.560 |
Why?
|
| Cues | 2 | 2016 | 80 | 0.560 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2018 | 9 | 0.560 |
Why?
|
| DNA-Binding Proteins | 12 | 2020 | 1939 | 0.560 |
Why?
|
| Neoplasm Proteins | 7 | 2021 | 680 | 0.550 |
Why?
|
| Rheology | 1 | 2018 | 24 | 0.550 |
Why?
|
| Synovial Fluid | 1 | 2018 | 15 | 0.550 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2020 | 588 | 0.550 |
Why?
|
| Organoids | 1 | 2021 | 305 | 0.540 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2021 | 155 | 0.540 |
Why?
|
| Dishevelled Proteins | 2 | 2017 | 40 | 0.540 |
Why?
|
| Fear | 2 | 2016 | 190 | 0.520 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2017 | 99 | 0.520 |
Why?
|
| Cell Movement | 5 | 2020 | 876 | 0.510 |
Why?
|
| Cell Separation | 7 | 2019 | 218 | 0.500 |
Why?
|
| rho-Associated Kinases | 1 | 2017 | 47 | 0.500 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2017 | 39 | 0.500 |
Why?
|
| Receptors, Estrogen | 7 | 2015 | 732 | 0.500 |
Why?
|
| Myeloid Cells | 4 | 2025 | 113 | 0.500 |
Why?
|
| DNA Repair | 4 | 2015 | 571 | 0.500 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2017 | 71 | 0.490 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 132 | 0.480 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2025 | 1011 | 0.480 |
Why?
|
| Reflex, Startle | 1 | 2016 | 34 | 0.480 |
Why?
|
| Antigens, Ly | 3 | 2011 | 31 | 0.480 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2015 | 252 | 0.480 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2015 | 6 | 0.460 |
Why?
|
| Carboplatin | 2 | 2015 | 79 | 0.460 |
Why?
|
| Vocalization, Animal | 1 | 2015 | 19 | 0.460 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2022 | 1272 | 0.460 |
Why?
|
| Oxytocin | 1 | 2016 | 68 | 0.460 |
Why?
|
| Models, Biological | 11 | 2020 | 1371 | 0.450 |
Why?
|
| Anti-Anxiety Agents | 1 | 2016 | 70 | 0.450 |
Why?
|
| Odorants | 1 | 2015 | 43 | 0.450 |
Why?
|
| Biosensing Techniques | 1 | 2016 | 81 | 0.450 |
Why?
|
| Simvastatin | 1 | 2015 | 76 | 0.440 |
Why?
|
| Maternal Behavior | 1 | 2015 | 66 | 0.440 |
Why?
|
| Ezetimibe | 1 | 2015 | 93 | 0.440 |
Why?
|
| Actin Cytoskeleton | 1 | 2015 | 48 | 0.430 |
Why?
|
| Cell Adhesion | 6 | 2022 | 308 | 0.430 |
Why?
|
| Doxorubicin | 2 | 2015 | 288 | 0.420 |
Why?
|
| Pregnancy | 31 | 2015 | 7512 | 0.420 |
Why?
|
| Hormones | 7 | 2010 | 162 | 0.420 |
Why?
|
| Aging | 2 | 2026 | 1242 | 0.410 |
Why?
|
| Receptors, Notch | 3 | 2015 | 197 | 0.400 |
Why?
|
| src-Family Kinases | 2 | 2025 | 92 | 0.400 |
Why?
|
| Base Sequence | 25 | 2011 | 2730 | 0.400 |
Why?
|
| Up-Regulation | 2 | 2015 | 825 | 0.390 |
Why?
|
| Hypercholesterolemia | 1 | 2015 | 230 | 0.380 |
Why?
|
| Phosphoproteins | 5 | 2016 | 448 | 0.380 |
Why?
|
| Anticholesteremic Agents | 1 | 2015 | 239 | 0.380 |
Why?
|
| Cyclophosphamide | 3 | 2026 | 428 | 0.380 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2012 | 6 | 0.370 |
Why?
|
| Behavior, Animal | 1 | 2015 | 480 | 0.370 |
Why?
|
| Transcription Factors | 7 | 2020 | 2406 | 0.360 |
Why?
|
| Disease Progression | 9 | 2019 | 2200 | 0.360 |
Why?
|
| Promoter Regions, Genetic | 9 | 2016 | 1207 | 0.360 |
Why?
|
| YY1 Transcription Factor | 2 | 2009 | 17 | 0.360 |
Why?
|
| Oncogenes | 5 | 2015 | 164 | 0.350 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2019 | 633 | 0.350 |
Why?
|
| Checkpoint Kinase 1 | 6 | 2011 | 26 | 0.350 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1722 | 0.350 |
Why?
|
| Coronary Disease | 1 | 2015 | 624 | 0.350 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 369 | 0.350 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2013 | 992 | 0.350 |
Why?
|
| Molecular Weight | 8 | 2021 | 276 | 0.340 |
Why?
|
| Phosphorylation | 12 | 2014 | 1571 | 0.340 |
Why?
|
| Haplotypes | 2 | 2010 | 519 | 0.340 |
Why?
|
| Neoplasm Transplantation | 7 | 2014 | 358 | 0.340 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2020 | 263 | 0.330 |
Why?
|
| Endoribonucleases | 2 | 2024 | 87 | 0.330 |
Why?
|
| Nanoshells | 1 | 2010 | 12 | 0.330 |
Why?
|
| Neoplasms, Experimental | 2 | 2011 | 201 | 0.330 |
Why?
|
| cdc25 Phosphatases | 3 | 2005 | 19 | 0.330 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2021 | 200 | 0.320 |
Why?
|
| Hyperthermia, Induced | 1 | 2010 | 50 | 0.320 |
Why?
|
| Gold | 1 | 2010 | 53 | 0.320 |
Why?
|
| Membrane Proteins | 5 | 2011 | 1590 | 0.310 |
Why?
|
| Erythropoiesis | 1 | 2010 | 39 | 0.310 |
Why?
|
| Mice, SCID | 6 | 2014 | 585 | 0.300 |
Why?
|
| Cell Transdifferentiation | 1 | 2010 | 57 | 0.300 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2011 | 1205 | 0.300 |
Why?
|
| Oncogene Proteins | 1 | 2010 | 136 | 0.300 |
Why?
|
| DNA Replication | 2 | 2009 | 355 | 0.300 |
Why?
|
| Biology | 1 | 2009 | 24 | 0.300 |
Why?
|
| Cell Line | 12 | 2020 | 2552 | 0.300 |
Why?
|
| Receptors, Fibroblast Growth Factor | 4 | 2003 | 57 | 0.290 |
Why?
|
| Anxiety | 1 | 2016 | 1014 | 0.290 |
Why?
|
| Cytokinesis | 1 | 2009 | 23 | 0.290 |
Why?
|
| Protein Isoforms | 4 | 2020 | 423 | 0.290 |
Why?
|
| NFI Transcription Factors | 2 | 2007 | 46 | 0.290 |
Why?
|
| Cell Cycle | 6 | 2016 | 594 | 0.280 |
Why?
|
| Genomic Instability | 2 | 2011 | 245 | 0.280 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2003 | 145 | 0.280 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 130 | 0.280 |
Why?
|
| Osteosarcoma | 1 | 2011 | 276 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 12 | 2020 | 4738 | 0.270 |
Why?
|
| Cells, Cultured | 8 | 2014 | 2885 | 0.270 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2008 | 82 | 0.270 |
Why?
|
| Lactation | 13 | 2015 | 195 | 0.270 |
Why?
|
| Transfection | 8 | 2018 | 962 | 0.260 |
Why?
|
| Integrases | 4 | 2015 | 157 | 0.260 |
Why?
|
| Morphogenesis | 4 | 2015 | 185 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 480 | 0.260 |
Why?
|
| Keratins | 2 | 2006 | 48 | 0.250 |
Why?
|
| Pyrimidines | 3 | 2021 | 446 | 0.250 |
Why?
|
| RNA, Double-Stranded | 2 | 2024 | 56 | 0.250 |
Why?
|
| Cyclin D1 | 2 | 2005 | 106 | 0.250 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2007 | 93 | 0.250 |
Why?
|
| Glucocorticoids | 1 | 2009 | 348 | 0.250 |
Why?
|
| Estrogen Receptor alpha | 2 | 2010 | 431 | 0.250 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2022 | 484 | 0.250 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2010 | 121 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 288 | 0.240 |
Why?
|
| DNA | 16 | 1996 | 1399 | 0.240 |
Why?
|
| Quality of Life | 1 | 2016 | 2082 | 0.240 |
Why?
|
| Neoplasm, Residual | 2 | 2022 | 136 | 0.240 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2006 | 101 | 0.240 |
Why?
|
| Transforming Growth Factor beta | 2 | 2006 | 451 | 0.240 |
Why?
|
| Protein Binding | 4 | 2026 | 1652 | 0.240 |
Why?
|
| CELF1 Protein | 1 | 2026 | 33 | 0.240 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2026 | 58 | 0.230 |
Why?
|
| Genes | 9 | 1986 | 308 | 0.230 |
Why?
|
| Flow Cytometry | 8 | 2019 | 765 | 0.230 |
Why?
|
| Precancerous Conditions | 2 | 2006 | 281 | 0.230 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 1545 | 0.230 |
Why?
|
| Anemia | 1 | 2010 | 354 | 0.230 |
Why?
|
| Cell Cycle Proteins | 3 | 2014 | 710 | 0.230 |
Why?
|
| Animals, Genetically Modified | 3 | 2013 | 291 | 0.230 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2026 | 83 | 0.220 |
Why?
|
| Sexual Maturation | 2 | 2016 | 45 | 0.220 |
Why?
|
| Dimerization | 5 | 2006 | 137 | 0.220 |
Why?
|
| Forkhead Transcription Factors | 3 | 2019 | 371 | 0.220 |
Why?
|
| Biguanides | 1 | 2025 | 14 | 0.220 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2016 | 429 | 0.220 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2026 | 144 | 0.220 |
Why?
|
| Glycoproteins | 1 | 2007 | 346 | 0.210 |
Why?
|
| RNA, Small Interfering | 5 | 2011 | 664 | 0.210 |
Why?
|
| Neoplasms, Hormone-Dependent | 4 | 2015 | 87 | 0.210 |
Why?
|
| Acetylation | 1 | 2025 | 190 | 0.210 |
Why?
|
| Taxoids | 1 | 2024 | 73 | 0.210 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2024 | 50 | 0.210 |
Why?
|
| Pyroptosis | 1 | 2024 | 35 | 0.210 |
Why?
|
| RNA Splicing | 4 | 2021 | 235 | 0.210 |
Why?
|
| Keratin-8 | 2 | 2015 | 12 | 0.210 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2021 | 114 | 0.200 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2025 | 359 | 0.200 |
Why?
|
| Receptors, Prolactin | 2 | 2002 | 24 | 0.200 |
Why?
|
| Down-Regulation | 4 | 2015 | 645 | 0.200 |
Why?
|
| Cell Size | 3 | 2016 | 77 | 0.200 |
Why?
|
| Molecular Targeted Therapy | 3 | 2021 | 386 | 0.200 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 555 | 0.200 |
Why?
|
| Carcinogenesis | 5 | 2019 | 336 | 0.200 |
Why?
|
| Frailty | 1 | 2026 | 140 | 0.200 |
Why?
|
| Mice, Nude | 4 | 2025 | 700 | 0.190 |
Why?
|
| Somatomedins | 1 | 2003 | 33 | 0.190 |
Why?
|
| Green Fluorescent Proteins | 5 | 2016 | 358 | 0.190 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2021 | 75 | 0.190 |
Why?
|
| Genomics | 1 | 2011 | 1621 | 0.190 |
Why?
|
| Interferons | 1 | 2023 | 138 | 0.190 |
Why?
|
| Cadherins | 3 | 2016 | 182 | 0.190 |
Why?
|
| Cytoskeletal Proteins | 2 | 2003 | 258 | 0.190 |
Why?
|
| Mitosis | 5 | 2020 | 191 | 0.180 |
Why?
|
| Recombinant Proteins | 4 | 2006 | 1319 | 0.180 |
Why?
|
| Transgenes | 5 | 2012 | 316 | 0.180 |
Why?
|
| Plasmids | 9 | 2005 | 449 | 0.180 |
Why?
|
| Nucleic Acid Hybridization | 18 | 1985 | 295 | 0.180 |
Why?
|
| Nuclear Proteins | 3 | 2003 | 1211 | 0.180 |
Why?
|
| Jagged-1 Protein | 1 | 2022 | 51 | 0.180 |
Why?
|
| Transplantation, Heterologous | 3 | 2011 | 255 | 0.180 |
Why?
|
| Puberty | 2 | 2015 | 94 | 0.180 |
Why?
|
| Phenotype | 8 | 2019 | 4497 | 0.180 |
Why?
|
| Heterozygote | 3 | 2011 | 737 | 0.170 |
Why?
|
| Natural Killer T-Cells | 1 | 2023 | 91 | 0.170 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 2 | 2012 | 9 | 0.170 |
Why?
|
| Disease Susceptibility | 2 | 2020 | 274 | 0.170 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2020 | 66 | 0.170 |
Why?
|
| Muscle Proteins | 1 | 2004 | 401 | 0.170 |
Why?
|
| Azacitidine | 1 | 2021 | 52 | 0.170 |
Why?
|
| Ribosomes | 3 | 2018 | 123 | 0.170 |
Why?
|
| Platelet Factor 4 | 1 | 2021 | 22 | 0.170 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 10 | 2001 | 53 | 0.170 |
Why?
|
| Leukemia | 1 | 2004 | 387 | 0.170 |
Why?
|
| Genes, p53 | 4 | 2010 | 208 | 0.170 |
Why?
|
| CD8 Antigens | 1 | 2021 | 39 | 0.170 |
Why?
|
| Dual-Specificity Phosphatases | 2 | 2011 | 23 | 0.170 |
Why?
|
| CD4 Antigens | 1 | 2021 | 54 | 0.170 |
Why?
|
| Blotting, Western | 4 | 2011 | 1013 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2015 | 821 | 0.170 |
Why?
|
| Benzamides | 1 | 2021 | 127 | 0.160 |
Why?
|
| Carrier Proteins | 1 | 2006 | 993 | 0.160 |
Why?
|
| Databases, Genetic | 1 | 2003 | 504 | 0.160 |
Why?
|
| Spliceosomes | 1 | 2021 | 47 | 0.160 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2020 | 22 | 0.160 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2020 | 36 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2021 | 188 | 0.160 |
Why?
|
| DNA Transposable Elements | 2 | 2020 | 178 | 0.160 |
Why?
|
| Stem Cell Niche | 1 | 2020 | 55 | 0.160 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2007 | 72 | 0.160 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2020 | 17 | 0.160 |
Why?
|
| Cell Survival | 4 | 2009 | 826 | 0.160 |
Why?
|
| Immunoenzyme Techniques | 3 | 2010 | 235 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 129 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 3 | 2013 | 1692 | 0.160 |
Why?
|
| Heterografts | 3 | 2015 | 191 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2007 | 688 | 0.150 |
Why?
|
| Transplants | 1 | 2020 | 38 | 0.150 |
Why?
|
| Immunity | 1 | 2021 | 178 | 0.150 |
Why?
|
| Transcriptional Activation | 5 | 2011 | 419 | 0.150 |
Why?
|
| RNA Stability | 1 | 2020 | 77 | 0.150 |
Why?
|
| Biomarkers | 4 | 2021 | 3385 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2014 | 597 | 0.150 |
Why?
|
| Organogenesis | 2 | 2010 | 75 | 0.150 |
Why?
|
| Gene Expression | 6 | 2013 | 1481 | 0.150 |
Why?
|
| Minimal Clinically Important Difference | 1 | 2019 | 7 | 0.150 |
Why?
|
| Proteostasis | 1 | 2020 | 37 | 0.150 |
Why?
|
| DNA Primers | 3 | 2011 | 599 | 0.150 |
Why?
|
| Estradiol | 6 | 2002 | 460 | 0.150 |
Why?
|
| Chromatin | 4 | 2011 | 499 | 0.150 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 208 | 0.150 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2022 | 511 | 0.150 |
Why?
|
| Aurora Kinase B | 2 | 2009 | 12 | 0.150 |
Why?
|
| Aurora Kinases | 2 | 2009 | 27 | 0.150 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 509 | 0.150 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2017 | 43 | 0.150 |
Why?
|
| Mitochondria | 1 | 2025 | 785 | 0.150 |
Why?
|
| Colony-Forming Units Assay | 2 | 2010 | 64 | 0.150 |
Why?
|
| Quinazolines | 3 | 2015 | 176 | 0.140 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 356 | 0.140 |
Why?
|
| Mice, Inbred NOD | 3 | 2021 | 299 | 0.140 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2019 | 62 | 0.140 |
Why?
|
| Cattle | 5 | 2006 | 501 | 0.140 |
Why?
|
| Tyrosine | 1 | 1999 | 142 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2010 | 410 | 0.140 |
Why?
|
| Zebrafish Proteins | 2 | 2003 | 133 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 587 | 0.140 |
Why?
|
| Male | 16 | 2026 | 64957 | 0.140 |
Why?
|
| Triterpenes | 1 | 2018 | 22 | 0.140 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2012 | 87 | 0.140 |
Why?
|
| Benzofurans | 1 | 2018 | 33 | 0.140 |
Why?
|
| Receptors, Steroid | 2 | 2011 | 167 | 0.140 |
Why?
|
| Viscosity | 1 | 2018 | 38 | 0.140 |
Why?
|
| Treatment Outcome | 5 | 2017 | 12936 | 0.140 |
Why?
|
| Homozygote | 2 | 2011 | 533 | 0.140 |
Why?
|
| Glycosaminoglycans | 1 | 2018 | 42 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 463 | 0.140 |
Why?
|
| Point-of-Care Testing | 1 | 2018 | 33 | 0.140 |
Why?
|
| Fibroblast Growth Factors | 2 | 2003 | 172 | 0.140 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 2904 | 0.130 |
Why?
|
| Spheroids, Cellular | 3 | 2014 | 59 | 0.130 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2017 | 14 | 0.130 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2018 | 32 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 354 | 0.130 |
Why?
|
| Pregnancy Complications | 1 | 2003 | 567 | 0.130 |
Why?
|
| Lentivirus | 3 | 2014 | 80 | 0.130 |
Why?
|
| RNA Helicases | 1 | 2018 | 73 | 0.130 |
Why?
|
| Gene Knockout Techniques | 2 | 2021 | 133 | 0.130 |
Why?
|
| Response Elements | 1 | 2018 | 102 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2016 | 142 | 0.130 |
Why?
|
| Molecular Sequence Data | 6 | 2012 | 3464 | 0.130 |
Why?
|
| Hydrocortisone | 9 | 2011 | 215 | 0.130 |
Why?
|
| Luminescent Proteins | 2 | 2016 | 142 | 0.130 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2009 | 223 | 0.130 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1998 | 150 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 236 | 0.130 |
Why?
|
| In Situ Hybridization | 2 | 2011 | 437 | 0.130 |
Why?
|
| Genetic Vectors | 4 | 2014 | 892 | 0.130 |
Why?
|
| Cell Culture Techniques | 2 | 2009 | 274 | 0.130 |
Why?
|
| Collagen | 2 | 2015 | 273 | 0.120 |
Why?
|
| Tamoxifen | 2 | 2015 | 348 | 0.120 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 224 | 0.120 |
Why?
|
| C-Reactive Protein | 2 | 2018 | 450 | 0.120 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2016 | 25 | 0.120 |
Why?
|
| Stem Cell Transplantation | 2 | 2015 | 227 | 0.120 |
Why?
|
| Oviducts | 8 | 1977 | 99 | 0.120 |
Why?
|
| Utilization Review | 1 | 2016 | 39 | 0.120 |
Why?
|
| Electroshock | 1 | 2016 | 20 | 0.120 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2020 | 544 | 0.120 |
Why?
|
| Cluster Analysis | 3 | 2013 | 414 | 0.120 |
Why?
|
| Tenascin | 1 | 2015 | 33 | 0.120 |
Why?
|
| Butyric Acid | 1 | 2015 | 7 | 0.120 |
Why?
|
| Polyribosomes | 2 | 2010 | 23 | 0.110 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2016 | 129 | 0.110 |
Why?
|
| Fever | 1 | 2018 | 312 | 0.110 |
Why?
|
| Rats, Long-Evans | 1 | 2015 | 95 | 0.110 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 57 | 0.110 |
Why?
|
| Obesity, Abdominal | 1 | 2015 | 39 | 0.110 |
Why?
|
| CD24 Antigen | 3 | 2013 | 32 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 378 | 0.110 |
Why?
|
| Cloning, Molecular | 6 | 1986 | 780 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2018 | 285 | 0.110 |
Why?
|
| Pain Management | 1 | 2017 | 205 | 0.110 |
Why?
|
| Enzyme Activation | 4 | 2020 | 576 | 0.110 |
Why?
|
| Lipoproteins, HDL | 1 | 2015 | 97 | 0.110 |
Why?
|
| Sialoglycoproteins | 2 | 2006 | 43 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 298 | 0.110 |
Why?
|
| Photic Stimulation | 1 | 2016 | 227 | 0.110 |
Why?
|
| Cell Line, Transformed | 3 | 2013 | 159 | 0.110 |
Why?
|
| Thiazoles | 1 | 2015 | 113 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2018 | 327 | 0.110 |
Why?
|
| Amino Acid Sequence | 7 | 2012 | 2395 | 0.110 |
Why?
|
| Cell Shape | 1 | 2015 | 67 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 145 | 0.110 |
Why?
|
| Integrin beta1 | 3 | 2013 | 51 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 2015 | 112 | 0.110 |
Why?
|
| Hyperplasia | 3 | 2016 | 191 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 1105 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2015 | 394 | 0.110 |
Why?
|
| Coculture Techniques | 1 | 2015 | 230 | 0.110 |
Why?
|
| Water | 1 | 2015 | 186 | 0.110 |
Why?
|
| RNA Interference | 3 | 2011 | 491 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2016 | 410 | 0.100 |
Why?
|
| Protein Multimerization | 2 | 2012 | 148 | 0.100 |
Why?
|
| Immunophenotyping | 1 | 2015 | 332 | 0.100 |
Why?
|
| Cellular Senescence | 3 | 2011 | 217 | 0.100 |
Why?
|
| Blood Vessels | 1 | 2014 | 92 | 0.100 |
Why?
|
| Structure-Activity Relationship | 3 | 2012 | 552 | 0.100 |
Why?
|
| Osteogenesis | 1 | 2015 | 182 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2017 | 801 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 716 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 3 | 2010 | 227 | 0.100 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2013 | 16 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 1336 | 0.100 |
Why?
|
| Biological Evolution | 3 | 1986 | 222 | 0.100 |
Why?
|
| DNA Copy Number Variations | 3 | 2016 | 1029 | 0.100 |
Why?
|
| Animals, Newborn | 2 | 2015 | 1021 | 0.100 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2005 | 95 | 0.090 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 1046 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 1267 | 0.090 |
Why?
|
| Triglycerides | 1 | 2015 | 602 | 0.090 |
Why?
|
| Lactalbumin | 3 | 1981 | 12 | 0.090 |
Why?
|
| Polycomb-Group Proteins | 1 | 2012 | 24 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2016 | 388 | 0.090 |
Why?
|
| COS Cells | 3 | 2006 | 253 | 0.090 |
Why?
|
| United States | 3 | 2018 | 12072 | 0.090 |
Why?
|
| Tacrolimus | 2 | 2003 | 100 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2013 | 229 | 0.090 |
Why?
|
| Collagen Type IV | 1 | 2011 | 20 | 0.090 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 604 | 0.090 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2024 | 128 | 0.090 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1626 | 0.090 |
Why?
|
| RNA, Neoplasm | 3 | 1981 | 125 | 0.090 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 55 | 0.090 |
Why?
|
| Fibronectins | 1 | 2011 | 99 | 0.090 |
Why?
|
| Organic Chemicals | 1 | 2011 | 58 | 0.090 |
Why?
|
| Aged | 4 | 2026 | 21025 | 0.090 |
Why?
|
| Collagen Type I | 1 | 2011 | 110 | 0.090 |
Why?
|
| Poly A | 6 | 1986 | 45 | 0.080 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 28 | 0.080 |
Why?
|
| Prostatic Neoplasms | 3 | 2003 | 1419 | 0.080 |
Why?
|
| Chromosomes | 2 | 2009 | 120 | 0.080 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2010 | 9 | 0.080 |
Why?
|
| DNA, Recombinant | 2 | 1981 | 71 | 0.080 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2010 | 13 | 0.080 |
Why?
|
| Cell Nucleolus | 1 | 2011 | 48 | 0.080 |
Why?
|
| Aging, Premature | 1 | 2011 | 31 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2015 | 1117 | 0.080 |
Why?
|
| Genes, Neoplasm | 1 | 2011 | 80 | 0.080 |
Why?
|
| Radiation, Ionizing | 1 | 2010 | 38 | 0.080 |
Why?
|
| Genetic Techniques | 1 | 2011 | 95 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2015 | 690 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 6797 | 0.080 |
Why?
|
| Rats, Inbred Strains | 7 | 1985 | 181 | 0.080 |
Why?
|
| Gene Transfer Techniques | 1 | 2012 | 344 | 0.080 |
Why?
|
| Cell Compartmentation | 1 | 2010 | 38 | 0.080 |
Why?
|
| Cell Dedifferentiation | 1 | 2010 | 20 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 246 | 0.080 |
Why?
|
| Embryo, Mammalian | 2 | 2011 | 403 | 0.080 |
Why?
|
| Kinetics | 9 | 2016 | 1088 | 0.080 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2025 | 170 | 0.080 |
Why?
|
| Phosphorylcholine | 1 | 2010 | 31 | 0.080 |
Why?
|
| Antigens, Differentiation | 1 | 2010 | 63 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 335 | 0.080 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 475 | 0.080 |
Why?
|
| In Vitro Techniques | 5 | 2007 | 808 | 0.080 |
Why?
|
| Cell Communication | 2 | 2011 | 188 | 0.080 |
Why?
|
| Immunoblotting | 2 | 2011 | 292 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2015 | 1345 | 0.080 |
Why?
|
| Pregnancy, Animal | 2 | 2001 | 66 | 0.080 |
Why?
|
| Staurosporine | 2 | 2011 | 21 | 0.080 |
Why?
|
| DNA, Complementary | 2 | 2011 | 422 | 0.080 |
Why?
|
| Mutation | 5 | 2017 | 6099 | 0.080 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 137 | 0.080 |
Why?
|
| Cytoplasm | 2 | 2021 | 249 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 189 | 0.080 |
Why?
|
| Thrombospondin 1 | 1 | 2009 | 23 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2009 | 152 | 0.070 |
Why?
|
| Cell Death | 1 | 2010 | 224 | 0.070 |
Why?
|
| Mammals | 2 | 2006 | 253 | 0.070 |
Why?
|
| Mice, Inbred Strains | 3 | 2006 | 263 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2009 | 1447 | 0.070 |
Why?
|
| Gene Amplification | 3 | 2021 | 219 | 0.070 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2009 | 37 | 0.070 |
Why?
|
| HeLa Cells | 3 | 2011 | 686 | 0.070 |
Why?
|
| Genome, Human | 2 | 2017 | 1321 | 0.070 |
Why?
|
| Carcinoma, Ductal | 1 | 2009 | 15 | 0.070 |
Why?
|
| Osteopontin | 2 | 2006 | 55 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 631 | 0.070 |
Why?
|
| Cyclin E | 2 | 2005 | 30 | 0.070 |
Why?
|
| Genes, ras | 2 | 2019 | 95 | 0.070 |
Why?
|
| Genes, Reporter | 3 | 2014 | 341 | 0.070 |
Why?
|
| Middle Aged | 4 | 2018 | 28601 | 0.070 |
Why?
|
| Multigene Family | 2 | 2003 | 290 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 289 | 0.070 |
Why?
|
| Ovalbumin | 5 | 1977 | 114 | 0.070 |
Why?
|
| Cell Transplantation | 1 | 2008 | 37 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 887 | 0.070 |
Why?
|
| Carcinoma in Situ | 1 | 2009 | 70 | 0.070 |
Why?
|
| Cell Count | 2 | 2020 | 212 | 0.070 |
Why?
|
| Nucleotidyltransferases | 1 | 2008 | 47 | 0.070 |
Why?
|
| Cell-Matrix Junctions | 2 | 2022 | 8 | 0.070 |
Why?
|
| Ovary | 1 | 2010 | 345 | 0.070 |
Why?
|
| Diethylstilbestrol | 4 | 1975 | 39 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 2 | 2006 | 197 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2009 | 365 | 0.070 |
Why?
|
| Acetylglucosamine | 1 | 2007 | 6 | 0.060 |
Why?
|
| Threonine | 1 | 2007 | 62 | 0.060 |
Why?
|
| Risk Factors | 3 | 2024 | 11074 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2007 | 6 | 0.060 |
Why?
|
| EGF Family of Proteins | 1 | 2007 | 12 | 0.060 |
Why?
|
| Amphiregulin | 1 | 2007 | 13 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2007 | 34 | 0.060 |
Why?
|
| Glycosylation | 1 | 2007 | 127 | 0.060 |
Why?
|
| Organ Culture Techniques | 6 | 2002 | 140 | 0.060 |
Why?
|
| Computational Biology | 3 | 2017 | 862 | 0.060 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2007 | 40 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1591 | 0.060 |
Why?
|
| Transcriptome | 1 | 2013 | 1103 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2003 | 975 | 0.060 |
Why?
|
| Keratin-6 | 1 | 2006 | 14 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2021 | 1483 | 0.060 |
Why?
|
| Nucleic Acid Precursors | 1 | 1986 | 1 | 0.060 |
Why?
|
| Serpins | 1 | 2006 | 34 | 0.060 |
Why?
|
| Poly(A)-Binding Protein I | 1 | 2026 | 6 | 0.060 |
Why?
|
| Acetylcysteine | 1 | 2007 | 79 | 0.060 |
Why?
|
| Gene Dosage | 2 | 2020 | 435 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2026 | 45 | 0.060 |
Why?
|
| RNA Polymerase II | 1 | 2006 | 83 | 0.060 |
Why?
|
| Parity | 3 | 2003 | 77 | 0.060 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2005 | 17 | 0.060 |
Why?
|
| Forecasting | 1 | 2007 | 351 | 0.060 |
Why?
|
| Fibroblasts | 4 | 2019 | 849 | 0.060 |
Why?
|
| Basement Membrane | 1 | 2005 | 41 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 241 | 0.060 |
Why?
|
| DNA, Neoplasm | 3 | 1972 | 282 | 0.060 |
Why?
|
| Neoadjuvant Therapy | 1 | 2008 | 400 | 0.060 |
Why?
|
| Genes, Homeobox | 1 | 2005 | 61 | 0.060 |
Why?
|
| Drug Resistance, Multiple | 1 | 2005 | 57 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2026 | 154 | 0.060 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 99 | 0.060 |
Why?
|
| Binding Sites | 3 | 2003 | 1133 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 248 | 0.060 |
Why?
|
| Protein Transport | 2 | 2020 | 366 | 0.060 |
Why?
|
| Lymphoma, Non-Hodgkin | 3 | 1972 | 163 | 0.060 |
Why?
|
| Bridged-Ring Compounds | 1 | 2024 | 19 | 0.050 |
Why?
|
| Dasatinib | 1 | 2025 | 49 | 0.050 |
Why?
|
| RNA | 4 | 1981 | 517 | 0.050 |
Why?
|
| S Phase | 1 | 2004 | 76 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2006 | 307 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 2 | 2003 | 300 | 0.050 |
Why?
|
| Species Specificity | 4 | 2015 | 470 | 0.050 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2003 | 41 | 0.050 |
Why?
|
| Time Factors | 6 | 2013 | 6196 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 82 | 0.050 |
Why?
|
| Cyclins | 1 | 2003 | 94 | 0.050 |
Why?
|
| Benz(a)Anthracenes | 1 | 1983 | 3 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2024 | 136 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2024 | 127 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1999 | 254 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 88 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2005 | 371 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 165 | 0.050 |
Why?
|
| Xenopus Proteins | 1 | 2003 | 55 | 0.050 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2023 | 14 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2002 | 7 | 0.050 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2002 | 19 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2003 | 112 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2024 | 154 | 0.050 |
Why?
|
| Prostatic Hyperplasia | 1 | 2003 | 110 | 0.050 |
Why?
|
| Phosphotyrosine | 1 | 2002 | 30 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2003 | 277 | 0.050 |
Why?
|
| Metformin | 1 | 2025 | 174 | 0.050 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2002 | 40 | 0.050 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2002 | 17 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2003 | 176 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 623 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 269 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2004 | 337 | 0.050 |
Why?
|
| Mutagenesis | 2 | 2001 | 324 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2021 | 17753 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2025 | 377 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2003 | 582 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 89 | 0.050 |
Why?
|
| Protein Precursors | 1 | 2002 | 140 | 0.040 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2002 | 68 | 0.040 |
Why?
|
| Chickens | 7 | 2010 | 267 | 0.040 |
Why?
|
| Wound Healing | 1 | 2005 | 490 | 0.040 |
Why?
|
| Codon | 2 | 1997 | 93 | 0.040 |
Why?
|
| Transplantation, Isogeneic | 1 | 2021 | 14 | 0.040 |
Why?
|
| Phylogeny | 1 | 2003 | 689 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2003 | 928 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2003 | 732 | 0.040 |
Why?
|
| Prognosis | 1 | 2010 | 4886 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 219 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2023 | 633 | 0.040 |
Why?
|
| Body Patterning | 2 | 2016 | 122 | 0.040 |
Why?
|
| Adult | 3 | 2018 | 31282 | 0.040 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 373 | 0.040 |
Why?
|
| Monitoring, Immunologic | 1 | 2020 | 15 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2020 | 6 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2003 | 644 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 37 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 278 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 1129 | 0.040 |
Why?
|
| DNA Restriction Enzymes | 4 | 1984 | 73 | 0.040 |
Why?
|
| Cricetinae | 2 | 1999 | 362 | 0.040 |
Why?
|
| Granulocytes | 1 | 2019 | 69 | 0.040 |
Why?
|
| Half-Life | 3 | 1985 | 149 | 0.040 |
Why?
|
| Lithium Chloride | 1 | 2019 | 6 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2019 | 83 | 0.040 |
Why?
|
| Cell Growth Processes | 2 | 2009 | 62 | 0.040 |
Why?
|
| CHO Cells | 1 | 1999 | 152 | 0.040 |
Why?
|
| Arthralgia | 1 | 2019 | 78 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 99 | 0.040 |
Why?
|
| Tritium | 7 | 1974 | 108 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2003 | 713 | 0.040 |
Why?
|
| Inflammation | 1 | 2006 | 1489 | 0.040 |
Why?
|
| Myxovirus Resistance Proteins | 1 | 2018 | 15 | 0.030 |
Why?
|
| Cocarcinogenesis | 1 | 1998 | 15 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1998 | 41 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 66 | 0.030 |
Why?
|
| Calcium | 1 | 1982 | 1010 | 0.030 |
Why?
|
| Glucose | 3 | 1972 | 853 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2020 | 516 | 0.030 |
Why?
|
| Carcinogens | 1 | 1998 | 127 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 355 | 0.030 |
Why?
|
| Hexoses | 3 | 1972 | 10 | 0.030 |
Why?
|
| Pyrroles | 1 | 2019 | 188 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2017 | 198 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 333 | 0.030 |
Why?
|
| Gene Library | 1 | 2017 | 212 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 301 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2016 | 40 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2018 | 231 | 0.030 |
Why?
|
| Enzymes | 1 | 1996 | 44 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 91 | 0.030 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2015 | 8 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2016 | 105 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 399 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2015 | 70 | 0.030 |
Why?
|
| Centrifugation, Density Gradient | 4 | 1983 | 55 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2017 | 483 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 1996 | 161 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 407 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 1287 | 0.030 |
Why?
|
| Genetic Code | 1 | 1974 | 22 | 0.030 |
Why?
|
| Fluorescence | 1 | 2014 | 94 | 0.030 |
Why?
|
| Pyridines | 1 | 2016 | 255 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2009 | 450 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 15 | 0.030 |
Why?
|
| Regeneration | 1 | 2016 | 230 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 85 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1996 | 324 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1986 | 330 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 42 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 90 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 200 | 0.020 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2013 | 15 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2016 | 349 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 276 | 0.020 |
Why?
|
| Microscopy, Electron | 3 | 1983 | 305 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 2085 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2013 | 130 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1882 | 0.020 |
Why?
|
| Cell Nucleus | 4 | 2002 | 556 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1295 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 889 | 0.020 |
Why?
|
| Leukemia L1210 | 1 | 1972 | 5 | 0.020 |
Why?
|
| Dexamethasone | 2 | 1970 | 250 | 0.020 |
Why?
|
| Methylnitrosourea | 2 | 2001 | 15 | 0.020 |
Why?
|
| Daunorubicin | 1 | 1972 | 26 | 0.020 |
Why?
|
| Casein Kinase I | 1 | 2012 | 11 | 0.020 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 2 | 2002 | 6 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2012 | 46 | 0.020 |
Why?
|
| Axin Protein | 1 | 2012 | 32 | 0.020 |
Why?
|
| Genotyping Techniques | 1 | 2012 | 110 | 0.020 |
Why?
|
| CpG Islands | 1 | 2013 | 337 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2012 | 60 | 0.020 |
Why?
|
| Promegestone | 1 | 2011 | 21 | 0.020 |
Why?
|
| Galactosides | 1 | 2011 | 9 | 0.020 |
Why?
|
| Progestins | 1 | 2011 | 39 | 0.020 |
Why?
|
| Luminescence | 1 | 2011 | 15 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1972 | 123 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2012 | 169 | 0.020 |
Why?
|
| Smoothened Receptor | 1 | 2011 | 31 | 0.020 |
Why?
|
| G2 Phase | 1 | 2011 | 39 | 0.020 |
Why?
|
| Hexokinase | 1 | 1970 | 21 | 0.020 |
Why?
|
| Goosecoid Protein | 1 | 2010 | 4 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 303 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2011 | 118 | 0.020 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2010 | 32 | 0.020 |
Why?
|
| Snail Family Transcription Factors | 1 | 2010 | 27 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 166 | 0.020 |
Why?
|
| Twist-Related Protein 1 | 1 | 2010 | 36 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2010 | 65 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1224 | 0.020 |
Why?
|
| Claudin-1 | 1 | 2009 | 19 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2011 | 199 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2010 | 94 | 0.020 |
Why?
|
| Prostate | 1 | 2012 | 404 | 0.020 |
Why?
|
| Hyaluronan Receptors | 1 | 2009 | 64 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2011 | 209 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 3829 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2009 | 26 | 0.020 |
Why?
|
| Fertility | 1 | 2011 | 260 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 305 | 0.020 |
Why?
|
| Memory | 1 | 2011 | 314 | 0.020 |
Why?
|
| Castration | 2 | 1978 | 27 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 2 | 1982 | 177 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 619 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 521 | 0.020 |
Why?
|
| RNA-Directed DNA Polymerase | 3 | 1976 | 38 | 0.020 |
Why?
|
| Genotype | 1 | 1973 | 2595 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6459 | 0.020 |
Why?
|
| Gene Deletion | 2 | 2002 | 767 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2008 | 387 | 0.020 |
Why?
|
| Lymphoma | 1 | 1970 | 327 | 0.020 |
Why?
|
| Thymidine | 3 | 1972 | 49 | 0.020 |
Why?
|
| Biological Transport | 2 | 2002 | 329 | 0.020 |
Why?
|
| Methods | 3 | 1975 | 95 | 0.020 |
Why?
|
| Carbon Isotopes | 3 | 1972 | 227 | 0.020 |
Why?
|
| Moloney murine sarcoma virus | 1 | 1986 | 2 | 0.010 |
Why?
|
| Triticum | 2 | 1976 | 29 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2013 | 1077 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1986 | 73 | 0.010 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2006 | 38 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1986 | 44 | 0.010 |
Why?
|
| RNA Precursors | 1 | 1986 | 42 | 0.010 |
Why?
|
| Temperature | 3 | 1976 | 291 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1986 | 252 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2010 | 791 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 1239 | 0.010 |
Why?
|
| Adipocytes | 1 | 2006 | 178 | 0.010 |
Why?
|
| Chromatography, Affinity | 2 | 1975 | 52 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2006 | 232 | 0.010 |
Why?
|
| Cell-Free System | 2 | 1975 | 62 | 0.010 |
Why?
|
| Escherichia coli | 2 | 1981 | 991 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1986 | 461 | 0.010 |
Why?
|
| Insulin | 2 | 1985 | 1149 | 0.010 |
Why?
|
| Cyclin A | 1 | 2003 | 16 | 0.010 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2003 | 20 | 0.010 |
Why?
|
| Research Design | 1 | 2008 | 716 | 0.010 |
Why?
|
| Heterochromatin | 1 | 2003 | 52 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2003 | 64 | 0.010 |
Why?
|
| Genes, myc | 1 | 2003 | 96 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 10103 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2003 | 53 | 0.010 |
Why?
|
| Blastula | 1 | 2003 | 1 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2003 | 79 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 2003 | 11 | 0.010 |
Why?
|
| Microvilli | 1 | 1983 | 61 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 300 | 0.010 |
Why?
|
| Gastrula | 1 | 2003 | 24 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1983 | 115 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1983 | 287 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1986 | 749 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2003 | 152 | 0.010 |
Why?
|
| Nervous System | 1 | 2003 | 114 | 0.010 |
Why?
|
| Depression, Chemical | 2 | 1972 | 33 | 0.010 |
Why?
|
| Uridine | 2 | 1972 | 31 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 2001 | 16 | 0.010 |
Why?
|
| Reproductive History | 1 | 2001 | 10 | 0.010 |
Why?
|
| Solute Carrier Family 12, Member 2 | 1 | 2001 | 4 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 15110 | 0.010 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 1983 | 156 | 0.010 |
Why?
|
| Sheep | 1 | 1982 | 229 | 0.010 |
Why?
|
| Connexins | 1 | 2001 | 63 | 0.010 |
Why?
|
| Growth Hormone | 1 | 2001 | 130 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2001 | 115 | 0.010 |
Why?
|
| DNA Nucleotidyltransferases | 2 | 1972 | 19 | 0.010 |
Why?
|
| Transformation, Bacterial | 1 | 1981 | 10 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 579 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1983 | 420 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 2002 | 138 | 0.010 |
Why?
|
| Reticulocytes | 1 | 1980 | 31 | 0.010 |
Why?
|
| Metabolism | 2 | 1970 | 45 | 0.010 |
Why?
|
| Drug Antagonism | 1 | 1980 | 13 | 0.010 |
Why?
|
| Dibutyryl Cyclic GMP | 1 | 1980 | 1 | 0.010 |
Why?
|
| Bucladesine | 1 | 1980 | 18 | 0.010 |
Why?
|
| Spermidine | 1 | 1980 | 5 | 0.010 |
Why?
|
| Organ Transplantation | 1 | 2002 | 175 | 0.010 |
Why?
|
| Avian Myeloblastosis Virus | 2 | 1976 | 4 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 555 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1980 | 90 | 0.010 |
Why?
|
| Rabbits | 1 | 1980 | 575 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 20987 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1980 | 220 | 0.010 |
Why?
|
| Lactose Synthase | 1 | 1978 | 1 | 0.010 |
Why?
|
| Steroids | 1 | 1980 | 170 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 2114 | 0.010 |
Why?
|
| Nafoxidine | 1 | 1977 | 4 | 0.010 |
Why?
|
| Child | 1 | 2018 | 26341 | 0.010 |
Why?
|
| Ploidies | 1 | 1997 | 35 | 0.010 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1997 | 27 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 1976 | 52 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1976 | 45 | 0.010 |
Why?
|
| Nucleic Acid Renaturation | 2 | 1973 | 3 | 0.010 |
Why?
|
| Nucleic Acid Denaturation | 2 | 1973 | 16 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 1973 | 40 | 0.010 |
Why?
|
| Aneuploidy | 1 | 1997 | 138 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1975 | 10 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1975 | 19 | 0.010 |
Why?
|
| Weaning | 1 | 1975 | 52 | 0.010 |
Why?
|
| Micropore Filters | 1 | 1974 | 2 | 0.010 |
Why?
|
| Avian Leukosis Virus | 1 | 1974 | 12 | 0.010 |
Why?
|
| Borohydrides | 1 | 1973 | 2 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1973 | 121 | 0.010 |
Why?
|
| Aminoisobutyric Acids | 1 | 1972 | 7 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1972 | 40 | 0.010 |
Why?
|
| Sarcoma, Experimental | 1 | 1972 | 15 | 0.010 |
Why?
|
| Valine | 1 | 1972 | 110 | 0.010 |
Why?
|
| Hexosephosphates | 1 | 1970 | 1 | 0.010 |
Why?
|
| Glucokinase | 1 | 1970 | 13 | 0.010 |
Why?
|
| Glycine | 1 | 1972 | 156 | 0.010 |
Why?
|
| Leucine | 1 | 1972 | 259 | 0.010 |
Why?
|
| Nucleosides | 1 | 1970 | 18 | 0.000 |
Why?
|
| Mice, Inbred C3H | 2 | 1978 | 95 | 0.000 |
Why?
|
| Amino Acids | 1 | 1970 | 566 | 0.000 |
Why?
|
| RNA, Viral | 2 | 1978 | 497 | 0.000 |
Why?
|
| Testosterone | 1 | 1970 | 531 | 0.000 |
Why?
|
| Karyotyping | 1 | 1982 | 308 | 0.000 |
Why?
|
| Placental Lactogen | 1 | 1978 | 2 | 0.000 |
Why?
|
| Cytarabine | 1 | 1978 | 100 | 0.000 |
Why?
|
| Fibroins | 1 | 1977 | 2 | 0.000 |
Why?
|
| Globins | 1 | 1977 | 20 | 0.000 |
Why?
|
| DNA Viruses | 1 | 1977 | 31 | 0.000 |
Why?
|
| Methylation | 1 | 1977 | 199 | 0.000 |
Why?
|
| Oviposition | 1 | 1975 | 6 | 0.000 |
Why?
|
| Mathematics | 1 | 1975 | 71 | 0.000 |
Why?
|
| Sepharose | 1 | 1974 | 9 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1974 | 64 | 0.000 |
Why?
|
| Drug Stability | 1 | 1973 | 56 | 0.000 |
Why?
|
| Cytosol | 1 | 1973 | 135 | 0.000 |
Why?
|
| Testis | 1 | 1974 | 389 | 0.000 |
Why?
|
| Uterus | 1 | 1974 | 541 | 0.000 |
Why?
|
| Liver | 1 | 1974 | 1796 | 0.000 |
Why?
|